Apr 6, 2009 by Michael P. Cecil, M.D.Investing in Pharma? Remember Rule No. 1Health care reform is likely this year. How will that affect your pharma investments?
May 19, 2008 by Michael P. Cecil, M.D.Berkshire Hathaway's Next CEO?The man who might replace the king writes about his own business principles and strategies.
Apr 2, 2008 by Michael P. Cecil, M.D.Irrational Exuberance for Vytorin and Zetia?A cardiologist examines the Enhance trial results.
Jul 18, 2007 by Michael P. Cecil, M.D.The World's Most Valuable CompaniesMore and more, they're popping up overseas.
May 7, 2007 by Michael P. Cecil, M.D.Buffett's Advice for Young InvestorsHow young? One visitor to the Berkshire Hathaway meeting isn't old enough for a paper route.
Mar 29, 2007 by Michael P. Cecil, M.D.Stents on TrialNew study results could affect stent sales -- at least in the short term.
Mar 19, 2007 by Michael P. Cecil, M.D.Pfizer's Newest Blockbuster?Will Chantix help Pfizer cure its ailing stock price?
Jan 22, 2007 by Michael P. Cecil, M.D.Will Medicare Negotiate With Drug Companies?One of the bedrock principles of our economic system is that those buying more of a product receive a discount.
Dec 11, 2006 by Michael P. Cecil, M.D.The Challenges of Valuing Drug CompaniesThe very nature of the pharmaceutical business makes valuing such companies difficult.
Dec 4, 2006 by Michael P. Cecil, M.D.Pfizer's Cholesterol-Drug Hopes CrumbleIn "surprising and disappointing" news, its promising new drug fails clinical trials.
Nov 8, 2006 by Michael P. Cecil, M.D.CVS/Caremark: A Brobdingnagian Drug SellerThe merger says a lot about companies that sell pharmaceuticals trying to deal with a rapidly changing paradigm.
Nov 7, 2006 by Michael P. Cecil, M.D.Will a 10-Bagger Go Higher?One study could boost the stock of a company with a special machine for heart patients.
Oct 31, 2006 by Michael P. Cecil, M.D.An Opening for PlavixNew data suggesting problems with drug-eluting stents may translate into more sales of the blood thinner and fewer sales of the stents.
Oct 23, 2006 by Michael P. Cecil, M.D.Are Pacemaker Prices Heading for a Fall?Medicare law changes may drive the amount that hospitals can pay for pacemakers.
Oct 17, 2006 by Michael P. Cecil, M.D.Bad News Is Good News for PfizerCelebrex is still shown to increase the risk of heart problems, but that might not be bad news for Pfizer shareholders.
Sep 27, 2006 by Michael P. Cecil, M.D.A Drug-Price Avalanche?Wal-mart's $4 generic-drug program could be the start of big changes in the $250 billion prescription-drug market.
